301 related articles for article (PubMed ID: 30239347)
21. DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV.
El-Garem H; AbdAllah M; Omar H; Cordie A; Abdel Alem S; Mohey Eldin Elzahry MA; Ghaith D; Abou El-Soud NH; Kamal W; Elsharkawy A; Esmat G
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):693-698. PubMed ID: 31043104
[No Abstract] [Full Text] [Related]
22. Predictors of functional benefit of hepatitis C therapy in a 'real-life' cohort.
Steinebrunner N; Stein K; Sandig C; Bruckner T; Stremmel W; Pathil A
World J Gastroenterol; 2018 Feb; 24(7):852-861. PubMed ID: 29467555
[TBL] [Abstract][Full Text] [Related]
23. Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals.
Olveira A; Domínguez L; Troya J; Arias A; Pulido F; Ryan P; Benítez LM; González-García J; Montes ML;
J Viral Hepat; 2018 Jul; 25(7):818-824. PubMed ID: 29476581
[TBL] [Abstract][Full Text] [Related]
24. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
Hsu WF; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen HY; Wang HW; Huang GT; Peng CY
BMC Gastroenterol; 2019 Apr; 19(1):63. PubMed ID: 31029101
[TBL] [Abstract][Full Text] [Related]
25. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H; Katano Y
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1066-1072. PubMed ID: 29727381
[TBL] [Abstract][Full Text] [Related]
26. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.
Sporea I; Sirli RL; Deleanu A; Popescu A; Focsa M; Danila M; Tudora A
Ultraschall Med; 2011 Jan; 32 Suppl 1():S46-52. PubMed ID: 20603783
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study.
Stasi C; Piluso A; Arena U; Salomoni E; Montalto P; Monti M; Boldrini B; Corti G; Marra F; Laffi G; Milani S; Zignego AL
World J Gastroenterol; 2015 Mar; 21(10):3013-9. PubMed ID: 25780300
[TBL] [Abstract][Full Text] [Related]
28. Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals.
Giannini EG; Crespi M; Demarzo M; Bodini G; Furnari M; Marabotto E; Torre F; Zentilin P; Savarino V
Eur J Clin Invest; 2019 Mar; 49(3):e13056. PubMed ID: 30474209
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
[TBL] [Abstract][Full Text] [Related]
30. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C.
Osakabe K; Ichino N; Nishikawa T; Sugiyama H; Kato M; Shibata A; Asada W; Kawabe N; Hashimoto S; Murao M; Nakano T; Shimazaki H; Kan T; Nakaoka K; Takagawa Y; Ohki M; Kurashita T; Takamura T; Yoshioka K
World J Gastroenterol; 2015 Sep; 21(35):10215-23. PubMed ID: 26401087
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals.
Fouad R; Elsharkawy A; Abdel Alem S; El Kassas M; Alboraie M; Sweedy A; Afify S; Abdellatif Z; Khairy M; Esmat G
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1129-1134. PubMed ID: 30896550
[TBL] [Abstract][Full Text] [Related]
32. Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan.
Wang JH; Changchien CS; Hung CH; Tung WC; Kee KM; Chen CH; Hu TH; Lee CM; Lu SN
J Gastroenterol Hepatol; 2010 May; 25(5):964-9. PubMed ID: 20546451
[TBL] [Abstract][Full Text] [Related]
33. Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis.
You MW; Kim KW; Shim JJ; Pyo J
J Gastroenterol Hepatol; 2021 Mar; 36(3):601-608. PubMed ID: 32875681
[TBL] [Abstract][Full Text] [Related]
34. Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis.
Singh S; Facciorusso A; Loomba R; Falck-Ytter YT
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):27-38.e4. PubMed ID: 28479504
[TBL] [Abstract][Full Text] [Related]
35. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
Sáez-Royuela F; Linares P; Cervera LA; Almohalla C; Jorquera F; Lorenzo S; García I; Karpman G; Badia E; Vallecillo MA; Moncada A; Calvo S; Olcoz JL;
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):305-12. PubMed ID: 26636405
[TBL] [Abstract][Full Text] [Related]
38. Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral Eradication.
Chen SH; Lai HC; Chiang IP; Su WP; Lin CH; Kao JT; Chuang PH; Hsu WF; Wang HW; Chen HY; Huang GT; Peng CY
Clin Infect Dis; 2020 Jan; 70(1):114-122. PubMed ID: 30816416
[TBL] [Abstract][Full Text] [Related]
39. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
40. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.
Alonso López S; Manzano ML; Gea F; Gutiérrez ML; Ahumada AM; Devesa MJ; Olveira A; Polo BA; Márquez L; Fernández I; Cobo JCR; Rayón L; Riado D; Izquierdo S; Usón C; Real Y; Rincón D; Fernández-Rodríguez CM; Bañares R
Hepatology; 2020 Dec; 72(6):1924-1934. PubMed ID: 33022803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
